Does ENCORAFENIB Cause Intestinal obstruction? 44 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 44 reports of Intestinal obstruction have been filed in association with ENCORAFENIB (BRAFTOVI). This represents 0.5% of all adverse event reports for ENCORAFENIB.
44
Reports of Intestinal obstruction with ENCORAFENIB
0.5%
of all ENCORAFENIB reports
3
Deaths
35
Hospitalizations
How Dangerous Is Intestinal obstruction From ENCORAFENIB?
Of the 44 reports, 3 (6.8%) resulted in death, 35 (79.5%) required hospitalization, and 3 (6.8%) were considered life-threatening.
Is Intestinal obstruction Listed in the Official Label?
Yes, Intestinal obstruction is listed as a known adverse reaction in the official FDA drug label for ENCORAFENIB.
What Other Side Effects Does ENCORAFENIB Cause?
Death (1,004)
Off label use (989)
Nausea (758)
Fatigue (685)
Diarrhoea (574)
Neoplasm progression (548)
Pyrexia (539)
Product use in unapproved indication (506)
Vomiting (429)
Rash (414)
What Other Drugs Cause Intestinal obstruction?
ADALIMUMAB (5,727)
VEDOLIZUMAB (1,263)
SEMAGLUTIDE (924)
INFLIXIMAB (907)
RISANKIZUMAB-RZAA (853)
BEVACIZUMAB (686)
LENALIDOMIDE (504)
CLOZAPINE (484)
OCTREOTIDE (463)
USTEKINUMAB (459)
Which ENCORAFENIB Alternatives Have Lower Intestinal obstruction Risk?
ENCORAFENIB vs ENDOXAN
ENCORAFENIB vs ENDOXAN BAXTER
ENCORAFENIB vs ENDOXAN INJ
ENCORAFENIB vs ENDOXAN , POUDRE POUR
ENCORAFENIB vs ENFORTUMAB VEDOTIN